Feb 8 2010
APCER
Pharma announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug
safety operations to APCER.
“APCER uses best in class, validated
processes and technology. Their staff have excellent training and
qualifications. Outsourcing our pharmacovigilance operations to the
experts at APCER allows LPC to focus our resources on our areas of
expertise.”
APCER is a leading global provider of comprehensive drug safety,
regulatory services and risk management programs for pharmaceutical,
biotechnology, medical device and consumer products companies.
LPC, based in Luton, specialises in the supply of branded and generic
medicines across the UK. It owns the intellectual property for over 150
licences enabling supply of own label and several brands such as Uvistat
sun cream, Dalivit Multivitamin Drops and Hill’s Balsam for Chesty and
Dry Cough.
LPC Director Satnam Butter said, “APCER uses best in class, validated
processes and technology. Their staff have excellent training and
qualifications. Outsourcing our pharmacovigilance operations to the
experts at APCER allows LPC to focus our resources on our areas of
expertise.”
Michael Reynolds, APCER’s Head of Sales and Marketing for Europe, Asia
and Africa, said, “We’re delighted to be working with LPC. Maintaining
the system is one of the most expensive, time-consuming burdens facing a
pharmaceutical company. APCER is 100% committed to our customers’
successes. We maintain continuous contact through visits and regular
updates, which enables smooth and efficient implementations. Our team
becomes an extension of every client’s operation.”
Pharmaceutical companies must invest more resources and budget to manage
their compliance with pharmacovigilance regulatory requirements within
ICH regions. APCER’s pharmacovigilance/drug safety experts provide a
complete range of services based on a fully electronic platform which is
compliant with ICH–E2B (EU) and 21 CFR part 11 (US-FDA) regulatory
requirements.